Abstract
EE80 Cost-Effectiveness of Ribociclib Plus a Non-Steroidal Aromatase Inhibitor for the Treatment of Pre- and Peri-Menopausal Women with HR+/HER2 Advanced Breast Cancer in Turkey
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have